Starr Wisdom - Oct 15, 2020 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
10%+ Owner
Signature
/s/ Starr Wisdom
Stock symbol
ORGO
Transactions as of
Oct 15, 2020
Transactions value $
-$5,958,964
Form type
4
Date filed
5/18/2021, 07:45 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Sale -$900K -200K -34.11% $4.50 386K Oct 15, 2020 Direct
transaction ORGO Class A Common Stock Sale -$334K -23.8K -6.17% $14.02 362K Feb 11, 2021 Direct
transaction ORGO Class A Common Stock Sale -$1.09M -85.5K -23.59% $12.76 277K Feb 12, 2021 Direct
transaction ORGO Class A Common Stock Sale -$194K -14K -5.06% $13.83 263K Feb 12, 2021 Direct
transaction ORGO Class A Common Stock Sale -$5.6K -400 -0.15% $14.00 263K Feb 12, 2021 Direct
transaction ORGO Class A Common Stock Sale -$2.2M -170K -64.75% $12.95 92.5K Feb 16, 2021 Direct
transaction ORGO Class A Common Stock Sale -$223K -15.2K -16.38% $14.70 77.4K Feb 24, 2021 Direct
transaction ORGO Class A Common Stock Sale -$403K -27.4K -35.39% $14.71 50K Feb 25, 2021 Direct
transaction ORGO Class A Common Stock Sale -$32.2K -1.95K -3.9% $16.50 48.1K Feb 25, 2021 Direct
transaction ORGO Class A Common Stock Sale -$133K -8.05K -16.75% $16.50 40K Mar 1, 2021 Direct
transaction ORGO Class A Common Stock Sale -$442K -20K -50% $22.11* 20K Apr 9, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Starr Wisdom, Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, and certain of their respective affiliates, including Organo PFG LLC, Organo Investors LLC, Dennis Erani 2012 Issue Trust, Alan Ades as Trustee of the Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, GN 2016 Family Trust u/a/d August 12, 2016 and GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, referred to collectively as the "Controlling Entities", are parties to a Controlling Stockholders' Agreement dated December 10, 2018 with Organogenesis Holdings Inc. (the "Stockholders' Agreement"). The Stockholders' Agreement, among other things, provides for nomination rights of the Controlling Entities with respect to four directors of the Issuer. As a result of the Stockholders' Agreement, the reporting person may be deemed to be a member of a group holding over 10% of the outstanding shares of common stock of the issuer for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. The reporting person disclaims beneficial ownership of the shares held by the other members of the Group and has no pecuniary interest in the shares held by the other members of the Group.